Medi-Caps Limited
BSE:523144 株式レポート
Medi-Caps マネジメント Medi-Capsの CEO はAlok Gargで、 Aug2016年に任命され、 の在任期間は 8.25年です。 の年間総報酬は₹ 3.34Mで、 100%給与と0%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の25.87%を直接所有しており、その価値は₹ 165.81M 。経営陣と取締役会の平均在任期間はそれぞれ4.8年と16.5年です。
主要情報 CEO給与比率 100.0% CEO在任期間 8.3yrs CEOの所有権 25.9% 経営陣の平均在職期間 4.8yrs 取締役会の平均在任期間 16.5yrs
経営陣の近況
Medi-Caps Limited, Annual General Meeting, Sep 26, 2024 Aug 07
Medi-Caps Limited Announces Retirement of Mr. Pramod Fatehpuria as Independent Director May 30
Insufficient new directors Mar 01
Medi-Caps Limited Announces Change in Management Nov 09
Medi-Caps Limited Approves Change in Designation of Gajendra Singh from Additional Director to Non Executive Independent Director Oct 01
Medi-Caps Limited, Annual General Meeting, Sep 29, 2023 Aug 30
すべての更新を表示
Medi-Caps Limited to Report Q2, 2025 Results on Nov 12, 2024 Nov 09
First quarter 2025 earnings released: ₹0.45 loss per share (vs ₹0.89 loss in 1Q 2024) Aug 08
Medi-Caps Limited, Annual General Meeting, Sep 26, 2024 Aug 07
Medi-Caps Limited to Report Q1, 2025 Results on Aug 07, 2024 Aug 02
Medi-Caps Limited Announces Retirement of Mr. Pramod Fatehpuria as Independent Director May 30
Full year 2024 earnings released: ₹1.80 loss per share (vs ₹1.50 profit in FY 2023) May 25
Medi-Caps Limited to Report Q4, 2024 Results on May 23, 2024 May 17
Insufficient new directors Mar 01
Third quarter 2024 earnings released: ₹0.13 loss per share (vs ₹1.04 loss in 3Q 2023) Feb 09
Second quarter 2024 earnings released: EPS: ₹0.09 (vs ₹1.74 in 2Q 2023) Nov 14
New minor risk - Share price stability Nov 13
Medi-Caps Limited Announces Change in Management Nov 09
Medi-Caps Limited Approves Change in Designation of Gajendra Singh from Additional Director to Non Executive Independent Director Oct 01
Medi-Caps Limited, Annual General Meeting, Sep 29, 2023 Aug 30
Medi-Caps Limited Appoints Gajendra Singh as an Additional Director Aug 12
Medi-Caps Limited to Report Q1, 2024 Results on Aug 11, 2023 Aug 05
Medi-Caps Limited Announces Resignation of Akshit Garg as Non Executive Non Independent Director Jul 14
Full year 2023 earnings released: EPS: ₹1.50 (vs ₹8.05 in FY 2022) May 25
Investor sentiment improves as stock rises 17% Apr 05
Third quarter 2023 earnings released: ₹1.04 loss per share (vs ₹1.67 profit in 3Q 2022) Feb 12
Medi-Caps Limited to Report Q3, 2023 Results on Feb 09, 2023 Feb 02
Medi-Caps Limited to Report Q2, 2023 Results on Nov 10, 2022 Nov 05
Investor sentiment deteriorated over the past week Aug 11
Medi-Caps Limited, Annual General Meeting, Sep 28, 2022 Aug 06
First quarter 2023 earnings released: EPS: ₹0.52 (vs ₹2.63 in 1Q 2022) Aug 05
Medi-Caps Limited to Report Q1, 2023 Results on Aug 04, 2022 Jul 28
Investor sentiment deteriorated over the past week Jun 17
Full year 2022 earnings released: EPS: ₹8.05 (vs ₹9.02 in FY 2021) May 30
Medi-Caps Limited to Report Q4, 2022 Results on May 25, 2022 May 18
Investor sentiment improved over the past week Apr 06
Investor sentiment deteriorated over the past week Feb 22
Investor sentiment deteriorated over the past week Feb 22
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 13
Medi-Caps Limited to Report Q3, 2022 Results on Feb 10, 2022 Feb 03
Second quarter 2022 earnings released: EPS ₹2.59 (vs ₹2.94 in 2Q 2021) Nov 12
Full year 2021 earnings released: EPS ₹11.16 (vs ₹4.69 loss in FY 2020) Jun 29
Investor sentiment improved over the past week May 25
Investor sentiment improved over the past week Mar 06
New 90-day high: ₹35.00 Mar 05
Investor sentiment improved over the past week Feb 12
New 90-day high: ₹29.45 Feb 08
Medi-Caps Limited Appoints Dharmendra Solanki as an Additional as Well as Non Executive Independent Director Feb 06
Third quarter 2021 earnings released: EPS ₹3.54 (vs ₹2.63 loss in 3Q 2020) Feb 06
Medi-Caps Limited to Report Q3, 2021 Results on Feb 05, 2021 Feb 01
New 90-day high: ₹24.65 Dec 09
Medi-Caps Limited Announces Demise of Shamsher Singh, Non-Executive Independent Director Nov 25
New 90-day high: ₹23.95 Nov 12
Medi-Caps Limited to Report Q2, 2021 Results on Nov 06, 2020 Oct 30
New 90-day high - ₹13.18 Jul 28
CEO報酬分析 Medi-Caps の収益と比較して、Alok Garg の報酬はどのように変化したか？ 日付 総報酬 給与 会社業績 Jun 30 2024 n/a n/a -₹17m
Mar 31 2024 ₹3m ₹3m -₹22m
Dec 31 2023 n/a n/a -₹8m
Sep 30 2023 n/a n/a -₹19m
Jun 30 2023 n/a n/a ₹1m
Mar 31 2023 n/a n/a ₹19m
Dec 31 2022 n/a n/a ₹29m
Sep 30 2022 n/a n/a ₹63m
Jun 30 2022 n/a n/a ₹74m
Mar 31 2022 n/a n/a ₹100m
Dec 31 2021 n/a n/a ₹109m
Sep 30 2021 n/a n/a ₹122m
Jun 30 2021 n/a n/a ₹121m
Mar 31 2021 ₹50k ₹50k ₹112m
Dec 31 2020 n/a n/a ₹80m
Sep 30 2020 n/a n/a ₹13m
Jun 30 2020 n/a n/a -₹41m
Mar 31 2020 ₹2m ₹2m -₹59m
Dec 31 2019 n/a n/a -₹24m
Sep 30 2019 n/a n/a ₹28m
Jun 30 2019 n/a n/a ₹78m
Mar 31 2019 ₹3m ₹3m ₹54m
Mar 31 2018 ₹3m ₹3m ₹11m
報酬と市場: Alokの 総報酬 ($USD 39.55K ) は、 Indian市場 ($USD 42.67K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Alokの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者 Mr. Alok K. Garg has been the Managing Director of Medi-Caps Limited since August 11, 2016. Mr. Garg serves as a Secretary of International Institute of Foreign Trade and Research. Mr. Garg has wide experi ... Show more
リーダーシップ・チーム 名称 ポジション 在職期間 報酬 所有権 MD & Whole-Time Director 8.3yrs ₹3.34m 25.87% ₹ 165.8m Chief Financial Officer 4.8yrs ₹1.25m データなし Company Secretary & Compliance Officer 3.1yrs ₹644.00k データなし
もっと見る
経験豊富な経営陣: 523144の経営陣は 経験豊富 であると考えられます ( 4.8年の平均在職年数)。
取締役 名称 ポジション 在職期間 報酬 所有権 MD & Whole-Time Director 25.6yrs ₹3.34m 25.87% ₹ 165.8m Non Executive Non Independent Chairman 41.3yrs データなし 0.080% ₹ 514.0k Non-Executive Woman Director 33.5yrs データなし 0.096% ₹ 616.8k Independent Non Executive Director 7.3yrs データなし データなし Non Executive Independent Director 3.8yrs データなし データなし Non-Executive Independent Director 1.3yrs データなし データなし
もっと見る
経験豊富なボード: 523144の 取締役会 は経験豊富で 経験豊富 です ( 16.5年の平均在任期間)。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}